Chinnery P F, Turnbull D M
The Medical School, The University of Newcastle upon Tyne, NE2 4HH, Newcastle upon Tyne, UK.
Mol Med Today. 2000 Nov;6(11):425-32. doi: 10.1016/s1357-4310(00)01805-0.
The coding sequence for the human mitochondrial genome (mtDNA) was published in 1981. Within a decade, the first pathogenic mtDNA mutations were described in humans with sporadic and maternally inherited disease. The last ten years has seen a profusion of reports describing new pathogenic mutations associated with a diverse range of clinical phenotypes. Although we have seen great advances in our understanding of the molecular mechanisms involved in the pathogenesis of mtDNA disease, we are only just beginning to tackle some of the more difficult questions. In this review we describe recent advances in our understanding of mtDNA disease and highlight ways that this knowledge might lead to novel therapies in the future.
人类线粒体基因组(mtDNA)的编码序列于1981年公布。在十年内,首次在患有散发性和母系遗传性疾病的人类中描述了致病性mtDNA突变。在过去十年中,大量报告描述了与多种临床表型相关的新致病性突变。尽管我们在理解mtDNA疾病发病机制所涉及的分子机制方面取得了巨大进展,但我们才刚刚开始解决一些更具挑战性的问题。在这篇综述中,我们描述了我们对mtDNA疾病理解的最新进展,并强调了这些知识可能在未来带来新疗法的方式。